Alentis Therapeutics
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hegenheimermattweg 167a, Allschwil, Base...Website
www.alentis.chRevenue
$16.9 MillionIndustry
ZI Rank: 1
About Alentis Therapeutics
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alentis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Alentis Therapeutics recently announced quarterly report
Check out if Alentis Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Alentis Therapeutics has new funding data
Check if Alentis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Alentis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Alentis Therapeutics
Product Launch: Get notified when Alentis Therapeutics launches new products
Click to see if Alentis Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Alentis Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Alentis Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alentis Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alentis Therapeutics.
Alentis Therapeutics financials insights
Gather financial insights about Alentis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$12.5M
Series B
$67M
Series C
$105M
Series D
$181.4M
Alentis Therapeutics Tech Stack
A closer look at the technologies used by Alentis Therapeutics
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alentis Therapeutics
Alentis Therapeutics is a clinical-stage biotech company dedicated to developing innovative therapies targeting cancer and fibrosis through Claudin-1. They focus on advancing a pipeline of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies, aiming to unlock the potential of this therapeutic target. Their clinical candidates in... Read More
